BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23180018)

  • 1. VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.
    Jin G; Zhou Y; Chai Q; Zhu G; Xu F; Liu F
    J Cancer Res Clin Oncol; 2013 Mar; 139(3):475-83. PubMed ID: 23180018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
    Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enhanced efficacy of herpes simplex virus by lentivirus mediated VP22 and cytosine deaminase gene therapy against glioma.
    Mi R; Fan W; Ji J; Dong C; Jin G; Liu F
    Brain Res; 2020 Sep; 1743():146898. PubMed ID: 32439343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
    Kim JH; Kim JY; Kim SU; Cho KG
    Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated CD/TK fusion gene transfection neural stem cell therapy for C6 glioblastoma.
    Niu J; Xing C; Yan C; Liu H; Cui Y; Peng H; Chen Y; Li D; Jiang C; Li N; Yang H
    Tumour Biol; 2013 Dec; 34(6):3731-41. PubMed ID: 23828263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.
    Lee KC; Hamstra DA; Bullarayasamudram S; Bhojani MS; Moffat BA; Dornfeld KJ; Ross BD; Rehemtulla A
    Gene Ther; 2006 Jan; 13(2):127-37. PubMed ID: 16163381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced suicide gene effect by adenoviral transduction of a VP22-cytosine deaminase (CD) fusion gene.
    Wybranietz WA; Gross CD; Phelan A; O'Hare P; Spiegel M; Graepler F; Bitzer M; Stähler P; Gregor M; Lauer UM
    Gene Ther; 2001 Nov; 8(21):1654-64. PubMed ID: 11895004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor efficacy of VP22-CD/5-FC suicide gene system mediated by lentivirus in a murine uveal melanoma model.
    Liu S; Song W; Liu F; Zhang J; Zhu S
    Exp Eye Res; 2018 Jul; 172():144-151. PubMed ID: 29660328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vectors.
    Jin GS; Zhu GD; Zhao ZG; Liu FS
    Clin Exp Med; 2012 Sep; 12(3):135-43. PubMed ID: 21874584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.
    Portnow J; Synold TW; Badie B; Tirughana R; Lacey SF; D'Apuzzo M; Metz MZ; Najbauer J; Bedell V; Vo T; Gutova M; Frankel P; Chen M; Aboody KS
    Clin Cancer Res; 2017 Jun; 23(12):2951-2960. PubMed ID: 27979915
    [No Abstract]   [Full Text] [Related]  

  • 12. Fusion of HSV-1 VP22 to a bifunctional chimeric SuperCD suicide gene compensates for low suicide gene transduction efficiencies.
    Lemken ML; Graepler F; Wolf C; Wybranietz WA; Smirnow I; Schmidt U; Gregor M; Bitzer M; Lauer UM
    Int J Oncol; 2007 May; 30(5):1153-61. PubMed ID: 17390017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
    Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
    Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors.
    Lai Z; Han I; Zirzow G; Brady RO; Reiser J
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11297-302. PubMed ID: 11027330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered cell therapy for sustained local myocardial delivery of nonsecreted proteins.
    Bian J; Kiedrowski M; Mal N; Forudi F; Penn MS
    Cell Transplant; 2006; 15(1):67-74. PubMed ID: 16700331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
    Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice.
    Xiong F; Xiao S; Peng F; Zheng H; Yu M; Ruan Y; Li W; Shang Y; Zhao C; Zhou W; Chen H; Chamberlain JS; Fang L; Zhang C
    Hum Gene Ther; 2007 Jun; 18(6):490-501. PubMed ID: 17550336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
    Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
    J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Treatment of Experimental Spinal Cord Glioma With Dual Gene-Engineered Human Neural Stem Cells.
    Ropper AE; Zeng X; Haragopal H; Anderson JE; Aljuboori Z; Han I; Abd-El-Barr M; Lee HJ; Sidman RL; Snyder EY; Viapiano MS; Kim SU; Chi JH; Teng YD
    Neurosurgery; 2016 Sep; 79(3):481-91. PubMed ID: 26671631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.
    Ito S; Natsume A; Shimato S; Ohno M; Kato T; Chansakul P; Wakabayashi T; Kim SU
    Cancer Gene Ther; 2010 May; 17(5):299-306. PubMed ID: 19893595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.